Reducing cancer treatment disparities for Latino children with leukemia
Improving Outcome Disparities for Latino Children and Adolescents with Acute Lymphoblastic Leukemia
This study is looking at why Latino kids and teens with acute lymphoblastic leukemia (ALL) often have tougher treatment experiences and lower survival rates, and it aims to find ways to improve their care and support.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10683983 on NIH RePORTER |
What this research studies
This research focuses on understanding and addressing the disparities in treatment outcomes for Latino children and adolescents diagnosed with acute lymphoblastic leukemia (ALL). It aims to identify biological and social factors that contribute to higher treatment-related toxicities and lower survival rates in this population. By investigating specific risks associated with hepatotoxicity and neurotoxicity, the research seeks to improve treatment strategies and healthcare access for affected patients. The ultimate goal is to establish a specialized program dedicated to enhancing outcomes for Latino pediatric leukemia patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are Latino children and adolescents diagnosed with acute lymphoblastic leukemia.
Not a fit: Patients who are not Latino or do not have acute lymphoblastic leukemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols and better survival rates for Latino children with leukemia.
How similar studies have performed: Previous research has shown that addressing ethnic disparities in cancer treatment can lead to improved outcomes, suggesting that this approach has potential for success.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Rabin, Karen R — Baylor College of Medicine
- Study coordinator: Rabin, Karen R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.